Please provide your email address to receive an email when new articles are posted on . VT-1953, a first-in-class topical immunomodulator, improved malodor associated with malignant fungating wounds ...
Malignant fungating wounds arise when cancerous cells infiltrate the skin, producing ulcerative or nodular lesions that are prone to pain, malodour, bleeding, necrosis and copious exudate. These ...
VT-1953 treatment significantly reduced malignant fungating wound-associated malodor (primary endpoint) (P<0.001). Patients also reported significant improvements in lesion pain (P<0.001) and Quality ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results